These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
506 related items for PubMed ID: 22623137
1. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J. Int J Cancer; 2012 Nov 01; 131(9):1969-82. PubMed ID: 22623137 [Abstract] [Full Text] [Related]
2. Comprehensive control of human papillomavirus infections and related diseases. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012. Vaccine; 2013 Nov 22; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716 [Abstract] [Full Text] [Related]
3. Comprehensive control of human papillomavirus infections and related diseases. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012. Vaccine; 2013 Dec 29; 31 Suppl 5():F1-31. PubMed ID: 24331745 [Abstract] [Full Text] [Related]
4. Epidemiology and burden of HPV-related disease. Serrano B, Brotons M, Bosch FX, Bruni L. Best Pract Res Clin Obstet Gynaecol; 2018 Feb 29; 47():14-26. PubMed ID: 29037457 [Abstract] [Full Text] [Related]
5. Cancers attributable to human papillomavirus infection. Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Sex Health; 2010 Sep 29; 7(3):244-52. PubMed ID: 20719211 [Abstract] [Full Text] [Related]
6. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review. Medeiros R, Vaz S, Rebelo T, Figueiredo-Dias M. Acta Med Port; 2020 Mar 02; 33(3):198-201. PubMed ID: 32130098 [Abstract] [Full Text] [Related]
7. HPV and HPV-associated diseases. Dunne EF, Park IU. Infect Dis Clin North Am; 2013 Dec 02; 27(4):765-78. PubMed ID: 24275269 [Abstract] [Full Text] [Related]
8. Burden of human papillomavirus infection and related diseases in Israel. Shavit O, Roura E, Barchana M, Diaz M, Bornstein J. Vaccine; 2013 Nov 22; 31 Suppl 8():I32-41. PubMed ID: 24229717 [Abstract] [Full Text] [Related]
9. Global burden of human papillomavirus and related diseases. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Vaccine; 2012 Nov 20; 30 Suppl 5():F12-23. PubMed ID: 23199955 [Abstract] [Full Text] [Related]
10. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L. Eur J Cancer; 2015 Sep 20; 51(13):1732-41. PubMed ID: 26121913 [Abstract] [Full Text] [Related]
11. Beyond cervical cancer: burden of other HPV-related cancers among men and women. Chaturvedi AK. J Adolesc Health; 2010 Apr 20; 46(4 Suppl):S20-6. PubMed ID: 20307840 [Abstract] [Full Text] [Related]
13. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Guo T, Eisele DW, Fakhry C. Cancer; 2016 Aug 01; 122(15):2313-23. PubMed ID: 27152637 [Abstract] [Full Text] [Related]
14. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art. Toh ZQ, Licciardi PV, Fong J, Garland SM, Tabrizi SN, Russell FM, Mulholland EK. Vaccine; 2015 Sep 22; 33(39):5042-50. PubMed ID: 26271829 [Abstract] [Full Text] [Related]
15. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Berman TA, Schiller JT. Cancer; 2017 Jun 15; 123(12):2219-2229. PubMed ID: 28346680 [Abstract] [Full Text] [Related]
16. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J. BMC Cancer; 2013 Jan 08; 13():10. PubMed ID: 23298365 [Abstract] [Full Text] [Related]
17. Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines. Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S. Int J Cancer; 2016 Aug 01; 139(3):510-7. PubMed ID: 26916230 [Abstract] [Full Text] [Related]
18. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates. Ong KJ, Checchi M, Burns L, Pavitt C, Postma MJ, Jit M. Sex Transm Infect; 2019 Feb 01; 95(1):28-35. PubMed ID: 30674687 [Abstract] [Full Text] [Related]
19. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Võrno T, Lutsar K, Uusküla A, Padrik L, Raud T, Reile R, Nahkur O, Kiivet RA. Vaccine; 2017 Nov 01; 35(46):6329-6335. PubMed ID: 28899625 [Abstract] [Full Text] [Related]
20. HPV in genital cancers (at the exception of cervical cancer) and anal cancers. de Sanjosé S, Bruni L, Alemany L. Presse Med; 2014 Dec 01; 43(12 Pt 2):e423-8. PubMed ID: 25455637 [Abstract] [Full Text] [Related] Page: [Next] [New Search]